Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases

OBJECTIVE: Administration of GnRH agonist (GnRHa) prior to chemotherapy may decreases the risk of gonadal dysfunction in patients with tumors. However, relevant data in haematopoietic stem cell transplantation (HSCT) recipients has not yet been established. Hence, the present study was designed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenhong, An, Jian, Wang, Chaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641837/
https://www.ncbi.nlm.nih.gov/pubmed/36345026
http://dx.doi.org/10.1186/s12905-022-02039-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641837/
https://www.ncbi.nlm.nih.gov/pubmed/36345026
http://dx.doi.org/10.1186/s12905-022-02039-8

Ejemplares similares